Molecular detection of some virulence genes of Proteus mirabilis in rheumatoid Ar-thritis patient’s urine and other clinical samples: Comparative study

Shahad Ali Kamil; Hawraa A Ali Aldahhan

doi:10.53730/ijhs.v6nS4.9835

Authors

Shahad Ali Kamil
shahadali101@gmail.com
Laboratory Investigations Department, Faculty of Science, University of Kufa, Najaf, Iraq
Hawraa A Ali Aldahhan Laboratory Investigations Department, Faculty of Science, University of Kufa, Najaf, Iraq

Keywords:

RA, proteus mirabilis, virulance genes, UreC, HmpA, ZapA genes

Abstract

This study was aimed to detecting three different virulence genes (UreC, HmpA and ZapA ) for Proteus mirabilis isolated from different clinical samples ( urine from UTI non-Rheumatoid arthritis patients, urine from UTI Rheumatoid arthritis patients, wound swaps , chronic supportive otitis media(CSOM) and cerebrospinal fluid aspirate(CSF). Three hundred (300) different clinical samples were collected and cultured on blood agar and macConky agar. 40 of samples were identified as P. mirabilis , biochemical test and VITEK 2 system used to complete the identification. Phenotypic detection appeared the present 100% of urease enzyme (on urea agar) hemolysin enzyme ( on blood agar), swarming phenomena (on agar plate ) while protease enzyme detection (on skim milk agar) present in 54% of isolates. Molecular results by PCR present UreC, HmpA and ZapA genes in 100 % in 40 isolates. Antibiotic Susceptibility test of Proteus mirabilis based on Kirby-Bauer disk diffusion method on Muller-Hinton agar to (14) different antimicrobial agents appeared 100% resistance to Aminoxicillin /clav, Cefotaxime and Erythromycin while the lowest resistance was against Impenem, Ciprofloxacin, Meropenem and Gentamicin (12.5%, 15 %, 20% and 47.5%), respectively.

Downloads

Download data is not yet available.

References

Al-Bassam, W. and Al-Kazaz, A., 2013. The Isolation and Characterization of Proteus mirabilis from Different Clinical Samples. Journal of Biotechnology Research Center, 7(2), pp.24-30.

Al-Duliami, A. A., Nauman, N. G., Hasan, A. R. S., and Al-Azawi, Z. H. ,2011. Virulence factors of Proteus Mirabilis isolated from patients otitis media in Baquba and it’s peripheries. Diyala Journal of Medicine, 1(1),pp. 69-75.

AL-Jumaa, M. H., 2011. Bacteriological and molecular study of some isolates of Proteus mirabilis and Proteus vulgris in Hilla Province. M.Sc. Thesis, College of Medicine, Babylon University.

Al-Mayahi, F. S., 2017. Phenotypic and Molecular detection of Virulence factors in Proteus mirabilis isolated from different clinical sources. Bas. J. Vet. Res, 16(1).‏‏

Armbruster, C. E., Mobley, H. L., and Pearson, M. M., 2018. Pathogenesis of Proteus mirabilis infection. EcoSal Plus, 8(1).

Bunyan, I. A., and Albakery, S. A., 2021. Molecular Detection of Some Virulence Factors of Uropathogenic Proteus mirabilis.‏Annals of Tropical Medicine and Public Health. (24).pp. 536-545.

Chalmeau, J., Monina, N., Shin, J., Vieu, C., and Noireaux, V., 2011. α-Hemolysin pore formation into a supported phospholipid bilayer using cell-free expression. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1808(1),pp. 271-278‏.

CLSI.(2022). Performance Standards for Antimicrobial Susceptibility Testing, Twentieth Informational Supplement, CLSI Document M100-Ed32 February 2022 Replaces M100-Ed31.

Costello, S. E., Deshpande, L. M., Davis, A. P., Mendes, R. E., and Castanheira, M., 2019. Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates. Journal of global antimicrobial resistance, 16, pp.278-285.‏

Dzutsev, A., and Trinchieri,G., 2015. Proteus mirabilis: the enemy within. Immunity, 42(4), pp.602-604.‏

Friedrich, A.W.; Koch, R.; Bielaszewska, M.; Zhang, W.; Karch, H. and Mathys, W.,2005. Distribution of the Urease gene cluster among urea activity of enterohemorrhagic Escherichia coli OH157 isolated from humans. J. of Clin. Micr. 43(2) , pp. 546-550.

Gibofsky, A., 2014. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A Synopsis. The American Journal of managed care, 20(7 Suppl), pp.S128-35‏.

Grahl, M. V., Uberti, A. F., Broll, V., Bacaicoa-Caruso, P., Meirelles, E. F., and Carlini, C. R., 2021. Proteus mirabilis urease: Unsuspected non-enzymatic properties relevant to pathogenicity. International journal of molecular sciences, 22(13),pp. 7205.

Hussain, H. I., Aqib, A. I., Seleem, M. N., Shabbir, M. A., Hao, H., Iqbal, Z., ... and Li, K., 2021. Genetic basis of molecular mechanisms in β-lactam resistant gram-negative bacteria. Microbial pathogenesis, 158, pp.105040.

Hussain,A.A., 2016. Comparative and Molecular Studies of Some Virulence Factors of Proteus spp. Isolated from Clinical and Environmental sources in Al -Najaf Al-Ashraf. PhD . thesis. Faculty of Science, Kufa University.

Jabur, M. H., AL- Saedi, I. A. and Trad, J. K., 2013. Isolation of Proteus mirabilis and Proteus vulgaris from different clinical sources and study of some virulence factors. J. of Bab. Univ. pure and applied sciences, 21(1), pp.43-48.

Jamal, M., Ahmad, W., Andleeb, S., Jalil, F., Imran, M., Nawaz, M. A., and Kamil, M. A., 2018. Bacterial biofilm and associated infections. Journal of the chinese medical association, 81(1),pp. 7-11.‏

Leelakrishna P, Karthik RB., 2018. A study of risk factors for catheter associated urinary tract infection. Int J Adv Med .5,pp.334-9.

MaccFadin, J.K., .2000. Biochemical test for identification of medical bacteria. (3rd ed .). Lippincott Williams and Winkins . Awolter Klumer Company . Philadelphia Baltimor .New York.

Mohammed, S. O., Ahmed, E. S., Hafez, E. E., Khalid, A., and ElShahaby, O. A., 2014. Characrerization and purification of urease enzyme from new Proteus mirabilis strain. Journal of Advanced Scientific Research, 5(4).

Mohsin Ali, R. I., Mohsin, M. I., and Al-Muhna, A., 2020. Validation of Horizontal Genes Transfer Using Selected Clinical Strain of P. mirabailis for Swarming Activity. Indian Journal of Forensic Medicine & Toxicology, 14(4).

Salama, L. A., Saleh, H., Abdel-Rhman, S., Barwa, R., and Hassan, R., 2021.Phenotypic and genotypic characterization of Extended Spectrum β-lactamases producing Proteus mirabilis isolates. Records of Pharmaceutical and Biomedical Sciences, 5 (Pharmacognosy-Microbiology), pp.89-99.‏

Schaffer, J. N.; and Pearson, M. M., 2015. Proteus mirabilis and urinary tract infections. Microbiology spectrum, 3(5).

Stankowska, D., Kwinkowski, M., and Kaca, W., 2008. Quantification of Proteus mirabilis virulence factors and modulation by acylated homoserine lactones. J Microbiol Immunol Infect, 41(3), pp.243-253.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

Yassen, L.T. and Khelkal, I.N.,2015. Effect of some fatty acid on virulence factors of Proteus mirabilis. Internal journal of advance biological research, 5(2), pp.108-117.

Yuan, F., Huang, Z., Yang, T., Wang, G., Li, P., Yang, B., and Li, J., 2021. Pathogenesis of Proteus mirabilis in Catheter-Associated Urinary Tract Infections. Urologia Internationalis, 105(5-6),pp. 354-361